Market Access Balancing efficiency with risks: How biopharma companies can... AI technologies can enable companies to program, rather than write, submissions to health authorities.
News New passport 'will speed medtech rollout in NHS' The UK has revealed a new 'innovator passport' designed to accelerate the rollout of proven medtech in the NHS.
News New medicine access times to be slashed under NHS plan Reports suggest a new framework for medicine reviews and a push to reduce NHS reliance on overseas-trained staff will feature in the 10-year plan.
News FDA loosens restrictions on first-gen CAR-T therapies There is enough experience with the first wave of autologous CAR-T therapies to allow strict rules ensuring their safe use to be relaxed, says FDA.
News FDA blocks trials that send US cells to 'hostile' countries The FDA says it will review clinical trials that send US citizens' cells to 'hostile countries' as the agency's leadership in this area is sidelined.
News Fired ACIP panel says RFK Jr is weakening vaccine programmes RFK Jr's interference in the ACIP is putting patients at risk, claim the 17 members of the panel abruptly fired last week.
News Immunovant's thyroid eye disease drug flunks pivotal trials Immunovant shares were sliding today after it reported that FcRn blocker batoclimab failed a pair of phase 3 trials in thyroid eye disease.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
